First 25-hydroxyvitamin D assay for general chemistry analyzers

Area of Science:

• Clinical Chemistry
• Biochemistry
• Analytical Chemistry

Background:

• 25-Hydroxyvitamin D [25(OH)D] is the primary circulating form of vitamin D, reflecting overall vitamin D status.
• Vitamin D deficiency is associated with various health conditions, including osteoporosis and rickets, underscoring the need for accurate 25(OH)D monitoring.
• Existing 25(OH)D assays (chromatographic and immunoassay-based) are typically heterogeneous, requiring phase separation and specialized equipment.

Purpose of the Study:

• To provide an overview of current 25(OH)D assay methodologies.
• To introduce the first homogeneous assay for 25(OH)D suitable for general chemistry analyzers.
• To highlight the analytical challenges specific to the 25(OH)D analyte.

Main Methods:

• Review of existing chromatographic (HPLC, LC-MS/MS) and immunoassay-based (ELISA, CLIA, FIA, RIA) methods for 25(OH)D.
• Development and description of a novel homogeneous 25(OH)D assay.
• Discussion of analytical challenges: low detection limits, analyte-transporter dissociation, and binding protein inactivation.

Main Results:

• Heterogeneous assay formats necessitate phase separation and specialized instrumentation.
• A novel homogeneous assay for 25(OH)D has been developed for use on standard clinical chemistry analyzers.
• Specific challenges related to the 25(OH)D analyte were addressed in the assay development.

Conclusions:

• The development of a homogeneous 25(OH)D assay simplifies clinical monitoring of vitamin D status.
• This new assay format offers an alternative to complex heterogeneous methods, potentially improving accessibility and efficiency.
• Addressing the unique analytical challenges of 25(OH)D is key to reliable vitamin D status assessment.